Prognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approach
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approach
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 41, Issue 9, Pages 101042831986362
Publisher
SAGE Publications
Online
2019-09-10
DOI
10.1177/1010428319863627
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The multiple functions and mechanisms of osteopontin
- (2018) Mehmet Arif Icer et al. CLINICAL BIOCHEMISTRY
- In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer
- (2018) Ran Wei et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The role of osteopontin in the progression of solid organ tumour
- (2018) Hailin Zhao et al. Cell Death & Disease
- Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases
- (2018) Sven Loosen et al. Journal of Clinical Medicine
- Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells
- (2017) Graciella M. Pio et al. PLoS One
- Precision Oncology: The Road Ahead
- (2017) Daniela Senft et al. TRENDS IN MOLECULAR MEDICINE
- Osteopontin -- a promising biomarker for cancer therapy
- (2017) Ran Wei et al. Journal of Cancer
- Association of colorectal cancer susceptibility variants with tumor subtypes in three large prospective cohorts.
- (2017) Xabier Garcia-Albeniz et al. JOURNAL OF CLINICAL ONCOLOGY
- High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma
- (2016) Nada Salem et al. Future Oncology
- Clinical significance of frequent somatic mutations detected by high-throughput targeted sequencing in archived colorectal cancer samples
- (2016) Ashraf Dallol et al. Journal of Translational Medicine
- Precision oncology is not an illusion
- (2016) Edward Abrahams et al. NATURE
- Perspective: The precision-oncology illusion
- (2016) Vinay Prasad NATURE
- Clinicopathological characteristics of young patients with sporadic colorectal cancer
- (2016) Asuka Murata et al. SURGERY TODAY
- New trends in molecular and cellular biomarker discovery for colorectal cancer
- (2016) Parisa Aghagolzadeh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Important molecular genetic markers of colorectal cancer
- (2016) Anna V. Kudryavtseva et al. Oncotarget
- Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis
- (2016) Xiaobin Gu et al. Oncotarget
- c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence
- (2015) Jaudah Al-Maghrabi et al. BMC CANCER
- Individualized medicine enabled by genomics in Saudi Arabia
- (2015) Muhammad Abu-Elmagd et al. BMC Medical Genomics
- Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma
- (2015) Jules Lin et al. Oncotarget
- Extracellular Molecules Involved in Cancer Cell Invasion
- (2015) Theodora Stivarou et al. Cancers
- Role of osteopontin in the pathophysiology of cancer
- (2014) Lalita A. Shevde et al. MATRIX BIOLOGY
- Differential β-catenin expression levels are associated with morphological features and prognosis of colorectal cancer
- (2014) ZHAO-HUA GAO et al. Oncology Letters
- The Polymorphisms of Osteopontin Gene and Plasma Osteopontin Protein Levels with Susceptibility to Colorectal Carcinoma
- (2013) Yu Fan et al. DNA AND CELL BIOLOGY
- An osteopontin promoter polymorphism is associated with aggressiveness in breast cancer
- (2013) DIVYA RAMCHANDANI et al. ONCOLOGY REPORTS
- Integrative Marker Analysis Allows Risk Assessment for Metastasis in Stage II Colon Cancer
- (2012) Ulrich Nitsche et al. ANNALS OF SURGERY
- Combination of Haptoglobin and Osteopontin Could Predict Colorectal Cancer Hepatic Metastasis
- (2012) Lichao Sun et al. ANNALS OF SURGICAL ONCOLOGY
- Reciprocal Interactions between Tumor-Associated Macrophages and CD44-Positive Cancer Cells via Osteopontin/CD44 Promote Tumorigenicity in Colorectal Cancer
- (2012) G. Rao et al. CLINICAL CANCER RESEARCH
- Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers
- (2012) Dong-Xing Cao WORLD JOURNAL OF GASTROENTEROLOGY
- Osteopontin is overexpressed in colorectal carcinoma and is correlated with P53 by immunohistochemistry
- (2012) JING LI et al. Experimental and Therapeutic Medicine
- Molecular predictive and prognostic markers in colon cancer
- (2010) Thomas Winder et al. CANCER TREATMENT REVIEWS
- The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis
- (2010) Yu-Wei Chiu et al. ORAL ONCOLOGY
- PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma
- (2009) A. Buhmeida et al. ANNALS OF ONCOLOGY
- Clinical Significance of the Upregulated Osteopontin mRNA Expression in Human Colorectal Cancer
- (2009) Wang Likui et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Post-translational modification and proteolytic processing of urinary osteopontin
- (2008) Brian Christensen et al. BIOCHEMICAL JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now